These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15243310)

  • 1. Treatment of kidney disease and anemia in elderly, long-term care residents.
    Tangalos EG; Hoggard JG; Murray AM; Thomas DR
    J Am Med Dir Assoc; 2004; 5(4 Suppl):H1-6. PubMed ID: 15243310
    [No Abstract]   [Full Text] [Related]  

  • 2. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness.
    Eschbach JW
    J Am Soc Nephrol; 2002 May; 13(5):1412-4. PubMed ID: 11961032
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectiveness of a pharmacist-implemented anemia management protocol in an outpatient hemodialysis unit.
    To LL; Stoner CP; Stolley SN; Buenviaje JD; Ziegler TW
    Am J Health Syst Pharm; 2001 Nov; 58(21):2061-5. PubMed ID: 11715828
    [No Abstract]   [Full Text] [Related]  

  • 4. [New treatments of anemia in chronic renal failure].
    Fernández Lorente L; Romero R
    Med Clin (Barc); 2014 Jul; 143(1):39-42. PubMed ID: 24467877
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythropoietin in kidney disease and type 2 diabetes.
    Thum T; Kalantar-Zadeh K; Anker SD
    N Engl J Med; 2011 Jan; 364(4):384-5; author reply 385-6. PubMed ID: 21268744
    [No Abstract]   [Full Text] [Related]  

  • 6. New developments in anemia management in chronic kidney disease.
    Amerling R; Besarab A; Roy C
    Nephrol News Issues; 2008 Mar; 22(3):suppl 1-8. PubMed ID: 18372676
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoiesis-stimulating agents in kidney and cardiac disease.
    Fluck R
    Br J Hosp Med (Lond); 2006 Oct; 67(10):533-7. PubMed ID: 17069130
    [No Abstract]   [Full Text] [Related]  

  • 8. Anemia in chronic kidney disease and congestive heart failure.
    Silverberg DS; Wexler D; Blum B; Iaina A
    Blood Purif; 2003; 21(1):124-30. PubMed ID: 12596758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Favourable effects of the treatment of renal anemia in early stage chronic renal failure].
    Kes P
    Lijec Vjesn; 2002; 124(3-4):108-9. PubMed ID: 18956830
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of anemia.
    Rao M; Muirhead N; Buoncristiani U
    Contrib Nephrol; 2004; 145():69-74. PubMed ID: 15496793
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al.".
    Belonje AM; de Boer RA; Voors AA
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):1-2. PubMed ID: 18219567
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of Carnitor for Epogen resistant anemia.
    Simard JC
    ANNA J; 1999 Feb; 26(1):41-2. PubMed ID: 10222857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anemia in chronic heart failure: should we treat it and how?
    Komajda M
    J Am Coll Cardiol; 2007 Feb; 49(7):763-4. PubMed ID: 17306704
    [No Abstract]   [Full Text] [Related]  

  • 14. Anemia management in dialysis: Why the FDA and CMS have it right (and how KDIGO got it wrong).
    Coyne DW
    Nephrol News Issues; 2013 Feb; 27(2):16, 18, 20. PubMed ID: 23469454
    [No Abstract]   [Full Text] [Related]  

  • 15. Epidemiology of chronic kidney disease and anemia.
    Robinson BE
    J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S3-6; quiz S17-21. PubMed ID: 17098633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of human recombinant erythropoietin (rHuEPO) for treatment of anemia in patients with chronic kidney failure who don't require additional dialysis therapy].
    Wiecek A
    Przegl Lek; 1995; 52(3):93-4. PubMed ID: 7644683
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complications of long-term hemodialysis patients and the countermeasures].
    Asano Y
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1273-8. PubMed ID: 1431471
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythropoietin for anemia of renal failure in sickle cell disease.
    Steinberg MH
    N Engl J Med; 1991 May; 324(19):1369-70. PubMed ID: 1759999
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure.
    Maxwell AP
    Kidney Int; 2002 Aug; 62(2):720-9. PubMed ID: 12110039
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Erythropoietin-Stimulating Agents (ESA) in Patients With End-Stage Renal Failure Decided to Forego Dialysis: Palliative Perspective.
    Cheng HW; Chan KY; Lau HT; Man CW; Cheng SC; Lam C
    Am J Hosp Palliat Care; 2017 May; 34(4):380-384. PubMed ID: 26718957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.